Dividend Policy Of Listed Companies Of China’s Pharmaceutical Research

With the advance of a new round of health care reform, the state investment continued to increase the people’s livelihood, the pharmaceutical industry is full of opportunities and challenges. Domestic and foreign many economists committed to the dividend policy, but For many dividend distribution of pharmaceutical companies in China irrational and can not make a satisfactory explanation. Dividend policy development role for the company’s future as one of the company’s most important financial policy, has a very important significance.This paper start with the traditional the financial dividend policy theories, combined with the pharmaceutical industry’s own characteristics and specific dividend Current Situation, the dividend payout ratio of pharmaceutical companies, multiple linear regression analysis to select the appropriate financial indicators, and tried from behavioral finance theory perspective to explain the dividend policy implications for the pharmaceutical industry factors, as well as some non-rational characteristics, and finally their own point of view as well as regulatory policy perspective from the pharmaceutical companies to develop mature dividend policy recommendations to help pharmaceutical companies in China in the fierce international competitors achieved an important position.